Cargando…
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
BACKGROUND: Lung squamous cell carcinoma (LSCC) remains a challenging disease to treat, and further improvements in prognosis are dependent upon the identification of LSCC-specific therapeutic biomarkers and/or targets. We previously found that Syntaxin Binding Protein 4 (STXBP4) plays a crucial rol...
Autores principales: | Bilguun, Erkhem-Ochir, Kaira, Kyoichi, Kawabata-Iwakawa, Reika, Rokudai, Susumu, Shimizu, Kimihiro, Yokobori, Takehiko, Oyama, Tetsunari, Shirabe, Ken, Nishiyama, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526255/ https://www.ncbi.nlm.nih.gov/pubmed/32993587 http://dx.doi.org/10.1186/s12885-020-07448-2 |
Ejemplares similares
-
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021) -
AKT3 is a key regulator of head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021) -
Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosis
por: Erkhem-Ochir, Bilguun, et al.
Publicado: (2020) -
Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas
por: Ohtaki, Yoichi, et al.
Publicado: (2019) -
Comprehensive expressional analysis of chemosensitivity‐related markers in large cell neuroendocrine carcinoma of the lung
por: Ohtaki, Yoichi, et al.
Publicado: (2021)